Contrast-Induced Acute Kidney Injury in Radiologic Management of Acute Ischemic Stroke in the Emergency Setting

References

1. 1.↵
   1. Brinjikji W,
   2. Demchuk AM,
   3. Murad MH, et al

   . Neurons over nephrons: systematic review and meta-analysis of contrast-induced nephropathy in patients with acute stroke. Stroke 2017;48:1862–68 doi:10.1161/STROKEAHA.117.016771 pmid:28583996

   Abstract/FREE Full Text
2. 2.↵
   1. Demel SL,
   2. Grossman AW,
   3. Khoury JC, et al

   . Association between acute kidney disease and intravenous dye administration in patients with acute stroke: a population-based study. Stroke 2017;48:835–39 doi:10.1161/STROKEAHA.116.014603 pmid:28258258

   Abstract/FREE Full Text
3. 3.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   ; American Heart Association Stroke Council. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–110 doi:10.1161/STR.0000000000000158 pmid:29367334

   Abstract/FREE Full Text
4. 4.↵
   1. Esteban JM,
   2. Cervera V

   . Perfusion CT and angio CT in the assessment of acute stroke. Neuroradiology 2004;46:705–15 doi:10.1007/s00234-004-1235-x pmid:15300343

   CrossRefPubMed
5. 5.↵
   1. Wildermuth S,
   2. Knauth M,
   3. Brandt T, et al

   . Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 1998;29:935–38 doi:10.1161/01.str.29.5.935 pmid:9596238

   Abstract/FREE Full Text
6. 6.↵
   1. van den Berg LA,
   2. Dijkgraaf MG,
   3. Berkhemer OA, et al

   ; MR CLEAN Investigators. Two-year outcome after endovascular treatment for acute ischemic stroke. N Engl J Med 2017;376:1341–49 doi:10.1056/NEJMoa1612136 pmid:28379802

   CrossRefPubMed
7. 7.
   1. Jovin TG,
   2. Chamorro A,
   3. Cobo E, et al

   ; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296–2306 doi:10.1056/NEJMoa1503780 pmid:25882510

   CrossRefPubMed
8. 8.↵
   1. Fransen PS,
   2. Berkhemer OA,
   3. Lingsma HF, et al

   ; Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands Investigators. Time to reperfusion and treatment effect for acute ischemic stroke: a randomized clinical trial. JAMA Neurol 2016;73:190–96 doi:10.1001/jamaneurol.2015.3886 pmid:26716735

   CrossRefPubMed
9. 9.↵
   1. Jia ZY,
   2. Wang SX,
   3. Zhao LB, et al

   . Risk of acute kidney injury with consecutive, multidose use of iodinated contrast in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2019;40:652–54 doi:10.3174/ajnr.A5959 pmid:30679214

   Abstract/FREE Full Text
10. 10.↵
    1. Hall SL,
    2. Munich SA,
    3. Cress MC, et al

    . Risk of acute kidney injury associated with neuroimaging obtained during triage and treatment of patients with acute ischemic stroke symptoms. J Neurointerv Surg 2016;8:1231–34 doi:10.1136/neurintsurg-2015-012118 pmid:26847330

    Abstract/FREE Full Text
11. 11.↵
    1. Sharma J,
    2. Nanda A,
    3. Jung RS, et al

    . Risk of contrast-induced nephropathy in patients undergoing endovascular treatment of acute ischemic stroke. J Neurointerv Surg 2013;5:543–55 doi:10.1136/neurintsurg-2012-010520 pmid:23125428

    Abstract/FREE Full Text
12. 12.↵
    1. Tao Y,
    2. Dong W,
    3. Li Z, et al

    . Proteinuria as an independent risk factor for contrast-induced acute kidney injury and mortality in patients with stroke undergoing cerebral angiography. J Neurointerv Surg 2017;9:445–48 doi:10.1136/neurintsurg-2016-012349 pmid:27106594

    Abstract/FREE Full Text
13. 13.↵
    1. Ang TE,
    2. Bivard A,
    3. Levi C, et al

    . Multi-modal CT in acute stroke: wait for a serum creatinine before giving intravenous contrast? No! Int J Stroke 2015;10:1014–17 doi:10.1111/ijs.12605 pmid:26306403

    CrossRefPubMed
14. 14.↵
    1. Lima FO,
    2. Lev MH,
    3. Levy RA, et al

    . Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. AJNR Am J Neuroradiol 2010;31:817–21 doi:10.3174/ajnr.A1927 pmid:20044502

    Abstract/FREE Full Text
15. 15.↵
    1. Ehrlich ME,
    2. Turner HL,
    3. Currie LJ, et al

    . Safety of computed tomographic angiography in the evaluation of patients with acute stroke: a single-center experience. Stroke 2016;47:2045–50 doi:10.1161/STROKEAHA.116.013973 pmid:27364528

    Abstract/FREE Full Text
16. 16.↵
    1. Wilhelm-Leen E,
    2. Montez-Rath ME,
    3. Chertow G

    . Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 2017;28:653–59 doi:10.1681/ASN.2016010021 pmid:27688297

    Abstract/FREE Full Text
17. 17.↵
    1. McDonald RJ,
    2. McDonald JS,
    3. Newhouse JH, et al

    . Controversies in contrast material-induced acute kidney injury: closing in on the truth? Radiology 2015;277:627–32 doi:10.1148/radiol.2015151486 pmid:26599922

    CrossRefPubMed
18. 18.↵
    1. Molen A,
    2. Reimer P,
    3. Dekkers IA, et al

    . Post-contrast acute kidney injury, Part 1: definition, clinical features, incidence, role of contrast medium and risk factors. Eur Radiol 2018;28:2845–55 doi:10.1007/s00330-017-5246-5 pmid:29426991

    CrossRefPubMed
19. 19.↵
    1. Barrett BJ,
    2. Parfrey PS

    . Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994;331:1449–50 doi:10.1056/NEJM199411243312111 pmid:7969286

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Feigin VL,
    2. Lawes CM,
    3. Bennett DA, et al

    . Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43–53 doi:10.1016/S1474-4422(03)00266-7 pmid:12849300

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Grysiewicz RA,
    2. Thomas K,
    3. Pandey DK

    . Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin 2008;26:871–95, vii doi:10.1016/j.ncl.2008.07.003 pmid:19026895

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Prencipe M,
    2. Culasso F,
    3. Rasura M, et al

    . Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. Stroke 1998;29:126–32 doi:10.1161/01.str.29.1.126 pmid:9445340

    Abstract/FREE Full Text
23. 23.↵
    1. Mair G,
    2. Wardlaw JM

    . Imaging of acute stroke prior to treatment: current practice and evolving techniques. Br J Radiol 2014;87:20140216 doi:10.1259/bjr.20140216 pmid:24936980

    CrossRefPubMed
24. 24.↵
    1. Lev MH,
    2. Farkas J,
    3. Rodriguez VR, et al

    . CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001;25:520–28 doi:10.1097/00004728-200107000-00003 pmid:11473180

    CrossRefPubMed
25. 25.↵
    1. Davenport MS,
    2. Khalatbari S,
    3. Cohan RH, et al

    . Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 2013;268:719–28 doi:10.1148/radiol.13122276 pmid:23579046

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Weisbord SD,
    2. Gallagher M,
    3. Jneid H, et al

    ; PRESERVE Trial Group. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 2018;378:603–14 doi:10.1056/NEJMoa1710933 pmid:29130810

    CrossRefPubMed
27. 27.↵
    1. Partovi S,
    2. Trischman T,
    3. Kang PS

    . Lessons learned from the PRESERVE trial. Br J Radiol 2018;91:20180092 doi:10.1259/bjr.20180092

    CrossRef